Orphan drug rules inflate prices, doctors claim

Doctors have urged the government to close a legal loophole they say allows companies to charge huge amounts by relicensing existing therapies for rare diseases.

Twenty consultants and a patient group have written an open letter to Prime Minister David Cameron and health secretary Andrew Lansley calling for an investigation.

They claim companies are exploiting orphan drugs rules to charge 'exorbitant' amounts for treatments otherwise available for much less.

The EU Orphan Regulation is designed to encourage drug companies to research rare diseases. But the authors claim many companies are instead applying for licences to repackage existing drugs for rare diseases.

The sole licence allows companies to charge dozens of times higher prices for drugs than existing treatments, the letter said.

The authors wrote: ‘In the present economic situation it seems vital to ensure that systems are in place to prevent excessive commercial profits being made at the expense of patients and public spending.'

The consultants conclude: ‘Legislation on orphan drugs, far from encouraging the development of new treatments for orphan diseases, is severely limiting the availability of existing treatments.

‘We believe that the MHRA and DoH should not just state the rules but should act now to progress the issue of unfairness upwards, so as to instigate change.’

In an accompanying article, Timothy Cox and colleagues at the University of Cambridge said orphan drug pricing hampers access to treatment and may warrant a competition law investigation.

They added current high pricing contravenes the aim of the Orphan Regulation, which states: ‘Patients suffering from rare conditions should be entitled to the same quality of treatment as other patients.’

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Follow Us:

Just published

Syringe extracting COVID-19 vaccine from vial

GP practices may need legal advice over mandatory COVID-19 jabs

GP practices 'may wish to seek individual HR and legal advice' on how to implement...

GP Job of the Week logo

GP Job of the Week: Salaried GP, Maidstone, Kent

The Mote Medical Practice in Maidstone, Kent is looking for a salaried GP to work...

Large letters reading RCGP

Most GPs fear impact of heavy workload on patient care this winter, RCGP poll shows

Three quarters of GPs fear growing workload pressure will undermine their ability...

Stethoscope on desk

Why a successful Northumberland practice is sticking by its decision not to join a PCN

After choosing not to join a primary care network back in 2019, a popular Northumberland...

How locum GPs should handle patient complaints

MDU medico-legal adviser Dr Kathryn Leask explains the particular challenges for...

Close up of a man turning off a light switch

GP's online carbon calculator helps practices cut emissions and save money

A Yorkshire GP has developed an online calculator that is helping practices to reduce...